Recap: F-star Therapeutics Q1 Earnings

 

F-star Therapeutics FSTX reported its Q1 earnings results on Tuesday, May 10, 2022 at 08:00 AM.

Here's what investors need to know about the announcement.

Earnings

F-star Therapeutics beat estimated earnings by 14.93%, reporting an EPS of $-0.57 versus an estimate of $-0.67.

Revenue was down $366.00 thousand from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.58 which was followed by a 1.81% increase in the share price the next day.

Here's a look at F-star Therapeutics's past performance:

 

Quarter Q4 2021 Q3 2021 Q2 2021 Q1 2021
EPS Estimate -0.11 -0.58 -0.74 -1.16
EPS Actual 0.47 -0.52 -0.92 -1.08
Revenue Estimate 9.98M 2.48M 750.00K 1.20M
Revenue Actual 17.50M 751.00K 0 2.92M

To track all earnings releases for F-star Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: EarningsNewsBZI-Recaps
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!